Division of Clinical Pathophysiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
EuroIntervention. 2013 May;9 Suppl R:R29-34. doi: 10.4244/EIJV9SRA6.
The persistence of high blood pressure under antihypertensive treatment (resistant hypertension) entails an increased cardiovascular risk. It occurs in three of ten treated hypertensive patients, and has several possible contributing factors, notably insufficient therapeutic adherence. There are a number of ways to evaluate whether patients take their medication as prescribed. These include interviewing the patient, pill counting, prescription follow-up, assay of drugs in blood or urine, and use of electronic pill dispensers. None is perfect. However, the essential is to discuss with the patient the importance of complying with the treatment as soon as it is prescribed for the first time, and not waiting for the appearance of resistant hypertension. The measurement of blood pressure outside the medical office and the monitoring of adherence may help to identify patients in whom hypertension is truly resistant and so to tailor the measures required to improve the control of blood pressure in the most appropriate manner.
在降压治疗下(难治性高血压)血压持续升高会增加心血管风险。在接受治疗的高血压患者中,每十人中就有三人会出现这种情况,其可能有多种促成因素,尤其是治疗的依从性不足。有很多方法可以评估患者是否按照规定服药。这些方法包括询问患者、数药片、处方跟踪、检测血液或尿液中的药物以及使用电子药盒。但没有一种方法是完美的。然而,关键是要在首次开出处方时就与患者讨论遵守治疗的重要性,而不是等到出现难治性高血压时再讨论。在医疗办公室外测量血压和监测依从性可能有助于识别真正存在高血压耐药的患者,从而以最合适的方式调整措施来改善血压控制。